Opendata, web and dolomites

GLINT SIGNED

GlucoCEST Imaging of Neoplastic Tumours

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "GLINT" data sheet

The following table provides information about the project.

Coordinator
UNIVERSITY COLLEGE LONDON 

Organization address
address: GOWER STREET
city: LONDON
postcode: WC1E 6BT
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website http://www.glint-project.eu
 Total cost 6˙454˙612 €
 EC max contribution 5˙797˙799 € (90%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-PHC-2015-two-stage
 Funding Scheme RIA
 Starting year 2016
 Duration (year-month-day) from 2016-01-01   to  2019-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    UNIVERSITY COLLEGE LONDON UK (LONDON) coordinator 1˙687˙712.00
2    TEL AVIV UNIVERSITY IL (TEL AVIV) participant 848˙325.00
3    MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV DE (MUENCHEN) participant 746˙912.00
4    UNIVERSITA DEGLI STUDI DI TORINO IT (TORINO) participant 739˙125.00
5    OLEA MEDICAL FR (LA CIOTAT) participant 731˙475.00
6    BRACCO IMAGING SPA IT (MILAN) participant 645˙250.00
7    EIBIR GEMEINNUTZIGE GMBH ZUR FORDERUNG DER ERFORSCHUNG DER BIOMEDIZINISCHEN BILDGEBUNG AT (WIEN) participant 399˙000.00
8    UNIVERSITAT ZURICH CH (ZURICH) participant 0.00

Map

 Project objective

Cancer is one of the most devastating diseases the world is currently facing, accounting for 7.6 million deaths in 2008 (WHO). Cancer is usually detected through advanced medical imaging. Early detection is very important as it increases the chances of survival and the potential for full recovery. Further, The high level of sophistication in treating cancer has led to a new unsolved problem, the differentiation between treatment effect, regrowth or pseudo-progression of the tumour. Here, we aim to develop and bring to the clinic a potentially disruptive new technology to characterize and image glucose delivery, uptake and metabolism in cancer. Recently we managed to demonstrate the sensitivity of a technique, named glucose-based Chemical Exchange Saturation Transfer (glucoCEST), to detect native (α-D-glucose) glucose uptake in tumours. In addition, recent developments have shown glucose analogues, such as 3-oxy-methyl-D-glucose (3OMG) can be used as potential non-metabolisable tracers using the same technique. In this proposal, we aim to bring the combination of native D-glucose and 3-oxy-methyl-D-glucose as a combined examination to the clinic to assess cancer glucose uptake and metabolism, thereby providing a cheap, widely available, more comprehensive, non-invasive alternative to nuclear medicine techniques currently used for cancer assessment within Europe.

 Deliverables

List of deliverables.
N-pool Bloch-McConnell simulation software Other 2019-05-31 15:08:48
pK by combined CEST / 13C NMR spectroscopy Documents, reports 2019-06-06 16:31:01
Assessment of GlucoCEST effect of 3OMG on a number of tumour models including from breast tumour cell lines DA3, 4T1, and MCF7 and brain metastases of the DA3 tumour cells. Documents, reports 2019-06-06 16:31:07
Assessment of in vivo pH dependence of GlucoCEST contrast in mouse tumour models using CEST-based agents Documents, reports 2019-06-06 16:31:00
Dependence of detection thresholds on administration ways Documents, reports 2019-05-31 15:08:56
Assessment of intracellular energy substrate levels upon native and methylated glucose injections Documents, reports 2019-05-31 15:08:46
Set up of website Websites, patent fillings, videos etc. 2019-05-31 15:08:55
Development and implementation of optimized MR T2 and T1ρ techniques Other 2019-06-06 16:37:05
Estimate of the coefficients of variation, signal- and contrast-to-noise of both sequences on volunteers Documents, reports 2019-05-31 15:08:54
Up-to-date steady-state and dynamic MRI sequences for GlucoCEST Demonstrators, pilots, prototypes 2019-05-31 15:08:58
Scanning of 1st adult patient for head-and-neck tumours and gliomas Demonstrators, pilots, prototypes 2019-05-31 15:09:00
Assessment of in vitro magnetic field dependence properties Documents, reports 2019-05-31 15:08:52
Technical validation of the GlucoCEST technique in human cancers Documents, reports 2019-05-31 15:08:55
Development and implementation of optimized MRI CEST sequences based, e.g. on SSFP Other 2019-06-06 16:31:08
Ethics protocols, informed consents and information sheets for scanning the right number of patients (incl. high field) Documents, reports 2019-05-31 15:08:48
Ethical approval for animal experiments, with personal licenses (incl. translation) Documents, reports 2019-05-31 15:08:56
Assessing the intra-/extracellular localisation of 3OMG by measuring pH Documents, reports 2019-05-31 15:08:46
Comparison of GlucoCEST contrast with [18F]FDG uptake Documents, reports 2019-06-06 16:30:58
Ethics for scanning children and scanning of first paediatric lymphoma patient Documents, reports 2019-04-30 20:38:12

Take a look to the deliverables list in detail:  detailed list of GLINT deliverables.

 Publications

year authors and title journal last update
List of publications.
2020 L.Mancini, S. Casagranda, F. Torrealdea, M.Rega, E. De Vita, B. Lopez, S. Brandner, B. Schmitt, P. Liebig, E. Sanverdi, X. Golay, S. Bisdas
Glioma staging with CEST asymmetry curves and amides/amines ratio
published pages: , ISSN: , DOI:
ISRM 2020 2020-03-05
2019 Mina Kim, Francisco Torrealdea, Sola Adeleke, Marilena Rega, Vincent Evans, Teresita Beeston, Katerina Soteriou, Stefanie Thust, Aaron Kujawa, Sachi Okuchi, Elizabeth Isaac, Wivijin Piga, Jonathan R. Lambert, Asim Afaq, Eleni Demetriou, Pratik Choudhary, King Kenneth Cheung, Sarita Naik, David Atkinson, Shonit Punwani, Xavier Golay
Challenges in glucoCEST MR body imaging at 3 Tesla
published pages: 1628-1640, ISSN: 2223-4292, DOI: 10.21037/qims.2019.10.05
Quantitative Imaging in Medicine and Surgery 9/10 2020-03-05
2019 Mina Kim , Marco Battiston , Eleni Demetriou , Aaron Kujawa , Torben Schneider , Vincent Evans , Sachi Okuchi , David Atkinson , Claudia Wheeler-Kingshott , Xavier Golay
Translating pH-sensitive PROgressive saturation for Quantifying Exchange using Saturation Times (PRO-QUEST) MRI to a 3T Clinical Scanner
published pages: , ISSN: , DOI:
ISMRM 2019 2020-03-05
2020 S. Casagranda, L. Mancini, G. Gautier, P. Peter, B. Lopez, S. Brandner, E. De Vita, X. Golay, and S. Bisdas
Fluid suppression in CEST imaging affects predominantly IDH-mutant 1p/19q retained gliomas with T2-FLAIR mismatch
published pages: , ISSN: , DOI:
ISMRM 2020 2020-03-05
2019 Aaron Kujawa , Eleni Demetriou , Mina Kim , Moritz Zaiss , Xavier Golay
Bayesian fitting of Chemical Exchange Saturation Transfer (CEST) imaging data with an analytical model for multiple CEST pools
published pages: , ISSN: , DOI:
ISMRM 2019 2020-03-05
2019 Aaron Kujawa, Mina Kim, Eleni Demetriou, Annasofia Anemone, Dario Livio Longo, Moritz Zaiss, Xavier Golay
Assessment of a clinically feasible Bayesian fitting algorithm using a simplified description of Chemical Exchange Saturation Transfer (CEST) imaging
published pages: 120-134, ISSN: 1090-7807, DOI: 10.1016/j.jmr.2019.01.006
Journal of Magnetic Resonance 300 2020-03-05
2017 Michal Rivlin, Gil Navon
CEST MRI of 3-O-methyl-D-glucose on different breast cancer models
published pages: , ISSN: 0740-3194, DOI: 10.1002/mrm.26752
Magnetic Resonance in Medicine 2019-07-02
2018 Moritz Zaiss, Goran Angelovski, Eleni Demetriou, Michael T. McMahon, Xavier Golay, Klaus Scheffler
QUESP and QUEST revisited - fast and accurate quantitative CEST experiments
published pages: 1708-1721, ISSN: 0740-3194, DOI: 10.1002/mrm.26813
Magnetic Resonance in Medicine 79/3 2019-07-02
2017 Annasofia Anemone, Lorena Consolino, Laura Conti, Francesca Reineri, Federica Cavallo, Silvio Aime, Dario Longo
In vivo evaluation of tumour acidosis for assessing the early metabolic response and onset of resistance to dichloroacetate by using magnetic resonance pH imaging
published pages: , ISSN: 1019-6439, DOI: 10.3892/ijo.2017.4029
International Journal of Oncology 2019-07-02
2018 Francesca Arena, Pietro Irrera, Lorena Consolino, Sonia Colombo Serra, Moritz Zaiss, Dario Livio Longo
Flip-angle based ratiometric approach for pulsed CEST-MRI pH imaging
published pages: 1-9, ISSN: 1090-7807, DOI: 10.1016/j.jmr.2017.12.007
Journal of Magnetic Resonance 287 2019-04-30
2019 Moritz Zaiss, Kai Herz, Anagha Deshmane, Mina Kim, Xavier Golay, Tobias Lindig, Benjamin Bender, Ulrike Ernemann, Klaus Scheffler
Possible artifacts in dynamic CEST MRI due to motion and field alterations
published pages: 16-22, ISSN: 1090-7807, DOI: 10.1016/j.jmr.2018.11.002
Journal of Magnetic Resonance 298 2019-04-30
2018 Michal Rivlin, Gil Navon
3-O-Methyl-d-glucose mutarotation and proton exchange rates assessed by 13C, 1H NMR and by chemical exchange saturation transfer and spin lock measurements
published pages: 93-103, ISSN: 0925-2738, DOI: 10.1007/s10858-018-0209-y
Journal of Biomolecular NMR 72/1-2 2019-04-30
2018 Ferrauto, Giuseppe; Di Gregorio, Enza; Lanzardo, Stefania; Ciolli, Laura; Iezzi, Manuela; Aime, Silvio
Generation of multiparametric MRI maps by using Gd-labelled- RBCs reveals phenotypes and stages of murine prostate cancer
published pages: , ISSN: 2045-2322, DOI: 10.1038/s41598-018-28926-5
Scientific Reports 2019-04-30
2017 Longo, Dario Livio; Moustaghfir, Fatima Zzahra; Zerbo, Alexandre; Consolino, Lorena; Anemone, Annasofia; Bracesco, Martina; Aime, Silvio
EXCI-CEST: Exploiting pharmaceutical excipients as MRI-CEST contrast agents for tumor imaging
published pages: , ISSN: 0378-5173, DOI: 10.1016/j.ijpharm.2017.04.040
International Journal of Pharmaceutics 2019-04-30
2018 Casagranda, Stefano; Pizzolato, Marco; Torrealdea, Francisco; Golay, Xavier; Boutelier, Timothé
Principal Process Analysis of dynamic GlucoCEST MRI data
published pages: , ISSN: , DOI:
ISMRM 2018 1 2019-04-30

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "GLINT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "GLINT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

LEGACy (2019)

CeLac and European consortium for a personalized medicine approach to Gastric Cancer

Read More  

SBR (2020)

SMART BONE REGENERATION

Read More  

ISLET (2020)

Advancing Innovative Stem Cell-based Therapy for Diabetes in Europe

Read More